Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Design, synthesis and antiviral activity of A-5021 discussed this week in Kyoto

Nov. 26, 1998

Preliminary results announced for pleconaril pediatric study; other trials in progress

Nov. 26, 1998

Herpesvirus protease inhibitors developed at SmithKline Beecham

Nov. 25, 1998

Pentose receives SBIR grant to support Inactine development

Nov. 25, 1998

Bayer claims broad-spectrum oxazolidinones

Nov. 23, 1998

Ajinomoto identifies mechanism of anti-HSV and anti-VZV actions of A-5021

Nov. 23, 1998

Erythromycin derivatives with high activity against sensitive and resistant microorganisms

Nov. 20, 1998

Picornavirus protease inhibitors from Agouron especially useful for rhinovirus infections

Nov. 20, 1998

Abbott obtains license to market Nyotran

Nov. 20, 1998

Increased dose strengths of Raxar now available in single-therapy box

Nov. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...